BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9864290)

  • 1. Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.
    Rinaldi-Carmona M; Le Duigou A; Oustric D; Barth F; Bouaboula M; Carayon P; Casellas P; Le Fur G
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1038-47. PubMed ID: 9864290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.
    Bouaboula M; Perrachon S; Milligan L; Canat X; Rinaldi-Carmona M; Portier M; Barth F; Calandra B; Pecceu F; Lupker J; Maffrand JP; Le Fur G; Casellas P
    J Biol Chem; 1997 Aug; 272(35):22330-9. PubMed ID: 9268384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    Bouaboula M; Poinot-Chazel C; Bourrié B; Canat X; Calandra B; Rinaldi-Carmona M; Le Fur G; Casellas P
    Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):637-41. PubMed ID: 8526880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
    Rinaldi-Carmona M; Barth F; Millan J; Derocq JM; Casellas P; Congy C; Oustric D; Sarran M; Bouaboula M; Calandra B; Portier M; Shire D; Brelière JC; Le Fur GL
    J Pharmacol Exp Ther; 1998 Feb; 284(2):644-50. PubMed ID: 9454810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
    FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
    Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
    Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways.
    Bouaboula M; Bianchini L; McKenzie FR; Pouyssegur J; Casellas P
    FEBS Lett; 1999 Apr; 449(1):61-5. PubMed ID: 10225429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
    Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
    Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist.
    Portier M; Rinaldi-Carmona M; Pecceu F; Combes T; Poinot-Chazel C; Calandra B; Barth F; le Fur G; Casellas P
    J Pharmacol Exp Ther; 1999 Feb; 288(2):582-9. PubMed ID: 9918562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.
    Eldeeb K; Leone-Kabler S; Howlett AC
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK; Alexander SP; Boyd EA; Kendall DA
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
    Shoemaker JL; Joseph BK; Ruckle MB; Mayeux PR; Prather PL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):868-75. PubMed ID: 15901805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalization cross-regulation.
    Bouaboula M; Desnoyer N; Carayon P; Combes T; Casellas P
    Mol Pharmacol; 1999 Mar; 55(3):473-80. PubMed ID: 10051530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
    Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
    Murphy JW; Kendall DA
    Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist.
    Shen CP; Xiao JC; Armstrong H; Hagmann W; Fong TM
    Eur J Pharmacol; 2006 Feb; 531(1-3):41-6. PubMed ID: 16438957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells.
    Bouaboula M; Bourrié B; Rinaldi-Carmona M; Shire D; Le Fur G; Casellas P
    J Biol Chem; 1995 Jun; 270(23):13973-80. PubMed ID: 7775459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CB1 receptors on rat neuronal cell cultures: binding and functional studies using the selective receptor antagonist SR 141716A.
    Jung M; Calassi R; Rinaldi-Carmona M; Chardenot P; Le Fur G; Soubrié P; Oury-Donat F
    J Neurochem; 1997 Jan; 68(1):402-9. PubMed ID: 8978752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
    Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.